Madrigal Pharmaceuticals (MDGL) Stock Chart & Stock Price History → Uncover this 2024 Hidden Gem (From Tips4Traders) (Ad) Free MDGL Stock Alerts $215.11 -3.27 (-1.50%) (As of 11:21 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Madrigal Pharmaceuticals Stock Price Performance5 Day Performance+1.45%1 Month Performance-13.33%3 Month Performance-3.50%6 Month Performance+70.16%Year-To-Date Performance-7.03%1 Year Performance-29.68% Receive MDGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him MDGL Stock Chart for Wednesday, April, 24, 2024 MDGL Chart by TradingView Madrigal Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$213.49$218.38+2.29%$225.66$210.10409,532 shs$4.35 billion04/22/2024$212.04$213.49+0.68%$217.14$197.86726,664 shs$4.25 billion04/19/2024$222.26$212.04-4.60%$224.68$206.03624,815 shs$4.22 billion04/18/2024$228.34$222.26-2.66%$227.31$220.74268,850 shs$4.42 billion04/17/2024$232.98$228.34-1.99%$235.91$224.39251,038 shs$4.54 billion04/16/2024$231.37$232.98+0.70%$235.92$222.90343,867 shs$4.64 billion Get the Latest News and Ratings for MDGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$236.59$231.37-2.21%$242.82$229.01322,867 shs$4.60 billion04/12/2024$245.27$236.59-3.54%$245.36$236.49294,850 shs$4.71 billion04/11/2024$244.67$245.27+0.25%$248.63$243.25212,540 shs$4.88 billion04/10/2024$249.34$244.67-1.87%$246.23$241.48226,258 shs$4.87 billion04/09/2024$248.64$249.34+0.28%$253.17$244.02226,947 shs$4.96 billion04/08/2024$243.04$248.64+2.30%$248.82$242.20238,450 shs$4.95 billion04/05/2024$241.46$243.04+0.65%$246.34$238.27295,908 shs$4.84 billion04/04/2024$245.23$241.46-1.54%$248.42$240.33385,216 shs$4.81 billion04/03/2024$244.50$245.23+0.30%$247.33$241.13490,313 shs$4.88 billion04/02/2024$255.74$244.50-4.40%$250.94$241.52593,301 shs$4.87 billion04/01/2024$267.04$255.74-4.23%$267.25$255.00546,968 shs$5.09 billion03/29/2024$267.04$267.04$268.22$254.75441,995 shs$5.31 billion03/28/2024$258.81$267.04+3.18%$268.22$254.87441,791 shs$5.31 billion03/27/2024$247.62$258.81+4.52%$259.53$244.85442,701 shs$5.15 billion03/26/2024$247.62$247.62$251.99$246.61234,085 shs$4.93 billion03/25/2024$248.20$247.62-0.23%$257.48$246.54394,413 shs$4.93 billion03/22/2024$255.27$248.20-2.77%$258.52$242.38529,937 shs$4.94 billion03/21/2024$258.99$255.27-1.44%$265.79$251.79376,212 shs$5.08 billion03/20/2024$265.68$258.99-2.52%$267.00$251.51674,651 shs$5.15 billion03/19/2024$283.23$265.68-6.20%$276.67$263.51915,038 shs$5.29 billion03/18/2024$270.37$283.23+4.76%$292.86$272.01963,934 shs$5.64 billion03/15/2024$243.57$270.37+11.00%$299.98$262.002.77 million shs$5.38 billion03/14/2024$272.98$243.57-10.77%$276.30$236.621.31 million shs$4.85 billion03/13/2024$262.67$272.98+3.93%$275.02$265.01765,507 shs$5.43 billion03/12/2024$260.15$262.67+0.97%$269.68$258.08596,475 shs$5.23 billion03/11/2024$255.32$260.15+1.89%$266.83$253.00678,833 shs$5.08 billion03/08/2024$251.03$255.32+1.71%$261.99$252.72475,422 shs$5.08 billion03/07/2024$257.38$251.03-2.47%$259.94$248.53400,598 shs$5.00 billion03/06/2024$248.49$257.38+3.58%$270.98$256.30680,508 shs$5.12 billion03/05/2024$246.56$248.49+0.78%$249.39$238.93386,211 shs$4.94 billion03/04/2024$251.63$246.56-2.01%$260.00$243.17500,152 shs$4.91 billion03/01/2024$236.20$251.63+6.53%$252.50$237.33452,394 shs$4.97 billion02/29/2024$254.23$236.20-7.09%$261.99$235.50512,043 shs$4.66 billion02/28/2024$239.80$254.23+6.02%$254.29$237.69487,028 shs$5.02 billionThousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage"02/27/2024$232.57$239.80+3.11%$242.97$233.06360,317 shs$4.73 billion02/26/2024$236.54$232.57-1.68%$241.63$214.00781,803 shs$4.59 billion02/23/2024$248.53$236.54-4.82%$249.98$235.08469,225 shs$4.67 billion02/22/2024$228.24$248.53+8.89%$253.00$230.47591,848 shs$4.91 billion02/21/2024$229.71$228.24-0.64%$235.02$225.02417,702 shs$4.51 billion02/20/2024$233.13$229.71-1.47%$238.55$227.00335,428 shs$4.53 billion02/19/2024$233.13$233.13$241.87$219.35607,400 shs$4.60 billion02/16/2024$222.22$233.13+4.91%$241.87$219.35607,284 shs$4.60 billion02/15/2024$217.98$222.22+1.95%$223.51$214.00384,488 shs$4.39 billion02/14/2024$204.80$217.98+6.44%$225.00$208.09533,448 shs$4.30 billion02/13/2024$216.33$204.80-5.33%$214.63$203.53677,376 shs$4.04 billion02/12/2024$189.88$216.33+13.93%$218.47$191.30955,870 shs$4.27 billion02/09/2024$171.37$189.88+10.80%$189.98$168.25898,017 shs$3.75 billion02/08/2024$188.54$171.37-9.11%$191.74$169.051.39 million shs$3.38 billion02/07/2024$201.44$188.54-6.40%$207.38$180.001.02 million shs$3.72 billion02/06/2024$227.05$201.44-11.28%$203.65$171.352.87 million shs$3.98 billion02/05/2024$220.28$227.05+3.07%$227.16$213.82394,361 shs$4.48 billion02/02/2024$222.23$220.28-0.88%$222.50$216.00167,480 shs$4.35 billion02/01/2024$216.71$222.23+2.55%$223.65$215.16262,628 shs$4.39 billion01/31/2024$221.07$216.71-1.97%$224.99$216.66240,109 shs$4.28 billion01/30/2024$226.99$221.07-2.61%$225.99$217.36265,321 shs$4.36 billion01/29/2024$225.97$226.99+0.45%$228.23$220.21223,089 shs$4.48 billion01/26/2024$230.17$225.97-1.82%$231.96$224.15234,812 shs$4.46 billion01/25/2024$222.91$230.17+3.26%$239.21$225.39248,753 shs$4.54 billion01/24/2024$229.00$222.91-2.66%$233.44$222.20263,079 shs$4.40 billion01/23/2024$233.18$229.00-1.79%$237.00$223.55236,730 shs$4.52 billion Related Companies: Alkermes Stock Chart Amicus Therapeutics Stock Chart Ionis Pharmaceuticals Stock Chart Rocket Pharmaceuticals Stock Chart Geron Stock Chart Dynavax Technologies Stock Chart Ironwood Pharmaceuticals Stock Chart Ligand Pharmaceuticals Stock Chart MannKind Stock Chart Y-mAbs Therapeutics Stock Chart Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDGL) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingPrepare for a recession unlike any otherAmerican Hartford Gold GroupExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.